Gradient Denervation Technologies
About:
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.
Website: http://www.gradientdenervation.com/
Top Investors: Asabys Partners, Sofinnova Partners, MD Start, Thuja Capital, MedTech Innovator
Description:
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.
Total Funding Amount:
14M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2019-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-09-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai